Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients at early stage of the disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07642908 · Parkinson Disease
NCT06680830 · Parkinson Disease, Parkinson, and more
NCT05822388 · Parkinson Disease, Movement Disorders
NCT06965374 · Parkinson Disease
NCT07250672 · Parkinson Disease, Virtual Reality, and more
St Joseph's Hospital and Medical Center, Barrow Neurology Clinics
Phoenix, Arizona
St. Joseph's Hospital and Medical Center
Phoenix, Arizona
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions